These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36901876)

  • 1. Investigating a Library of Flavonoids as Potential Inhibitors of a Cancer Therapeutic Target MEK2 Using in Silico Methods.
    AlZahrani WM; AlGhamdi SA; Sohrab SS; Rehan M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Natural Compounds in Flavonoids for Their Potential Inhibition of Cancer Therapeutic Target MEK1 Using Computational Methods.
    AlZahrani WM; AlGhamdi SA; Zughaibi TA; Rehan M
    Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation studies, 3D QSAR and molecular docking on a point mutation of protein kinase B with flavonoids targeting ovarian Cancer.
    Ajjarapu SM; Tiwari A; Taj G; Singh DB; Singh S; Kumar S
    BMC Pharmacol Toxicol; 2021 Nov; 22(1):68. PubMed ID: 34727985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxygenase directed anti-inflammatory and anti-cancerous secondary metabolites: ADMET-based screening, molecular docking and dynamics simulation.
    Singh S; Awasthi M; Pandey VP; Dwivedi UN
    J Biomol Struct Dyn; 2017 Feb; 35(3):657-668. PubMed ID: 26942689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study.
    Bitew M; Desalegn T; Demissie TB; Belayneh A; Endale M; Eswaramoorthy R
    PLoS One; 2021; 16(12):e0260853. PubMed ID: 34890431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
    Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
    J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction.
    Rasul HO; Aziz BK; Ghafour DD; Kivrak A
    Mol Divers; 2023 Oct; 27(5):2273-2296. PubMed ID: 36318405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Exploration of Naturally Occurring Flavonoids as TGF-β Inhibitors in Breast Cancer: Insights from Docking and Molecular Dynamics Simulations and In-vitro Cytotoxicity Study.
    Shah U; Patel N; Patel M; Rohit S; Solanki N; Patel A; Patel S; Patel V; Patel R; Jawarkar RD
    Chem Biodivers; 2024 Jun; 21(6):e202301903. PubMed ID: 38623839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in silico molecular docking and simulation study to identify potential anticancer phytochemicals targeting the RAS signaling pathway.
    Azmal M; Paul JK; Prima FS; Talukder OF; Ghosh A
    PLoS One; 2024; 19(9):e0310637. PubMed ID: 39298437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico molecular docking and dynamic simulation of eugenol compounds against breast cancer.
    Rasul HO; Aziz BK; Ghafour DD; Kivrak A
    J Mol Model; 2021 Dec; 28(1):17. PubMed ID: 34962586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modelling of SdiA protein by selected flavonoid and terpenes compounds to attenuate virulence in
    Adeosun IJ; Baloyi I; Aljoundi AK; Salifu EY; Ibrahim MA; Cosa S
    J Biomol Struct Dyn; 2023 Nov; 41(19):9938-9956. PubMed ID: 36416609
    [No Abstract]   [Full Text] [Related]  

  • 15. Virtual screening, molecular docking, MD simulation studies, DFT calculations, ADMET, and drug likeness of Diaza-adamantane as potential MAPK
    Gheidari D; Mehrdad M; Hoseini F
    Front Pharmacol; 2024; 15():1360226. PubMed ID: 39021828
    [No Abstract]   [Full Text] [Related]  

  • 16. Flavonoids as promising anticancer agents: an
    Biharee A; Yadav A; Jangid K; Singh Y; Kulkarni S; Sawant DM; Kumar P; Thareja S; Jain AK
    J Biomol Struct Dyn; 2023; 41(16):7835-7846. PubMed ID: 36165610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics.
    Oany AR; Mia M; Pervin T; Junaid M; Hosen SMZ; Moni MA
    Int J Antimicrob Agents; 2020 Dec; 56(6):106177. PubMed ID: 32987103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
    Gnanaraj C; Sekar M; Fuloria S; Swain SS; Gan SH; Chidambaram K; Rani NNIM; Balan T; Stephenie S; Lum PT; Jeyabalan S; Begum MY; Chandramohan V; Thangavelu L; Subramaniyan V; Fuloria NK
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer.
    Awasthi M; Singh S; Pandey VP; Dwivedi UN
    J Biomol Struct Dyn; 2015; 33(4):804-19. PubMed ID: 24702656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
    Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.